Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Alma Therapeutics Ltd. has 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are being handled by 3 distinct examiners. Despite having 3 distinct examiners, all pending actions are concentrated within 1 distinct art unit.
VOKES, KATHLEEN PAIGE is the busiest examiner for the company with 1 pending action. The focus on 1 distinct art unit suggests a very specific technical area for the portfolio. However, the presence of 3 distinct examiners means the company must navigate different individual perspectives within that single art unit.
With 3 pending office actions and 3 distinct examiners, there is no examiner overlap. This requires the company to tailor its prosecution strategy to different individuals, even though they are all working within the same technical group. The 1 action per examiner ensures a distributed review process.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VOKES, KATHLEEN PAIGE | 1 | 55.1% | +25.9% |
| GONZALEZ, LEI NMN | 1 | 42.9% | +51.8% |
| MARRISON, SAMUEL JOSEPH | 1 | 68.8% | +40.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19105361 | AUTO-INFLATABLE PATCH ASSEMBLY FOR DELIVERY OF THERAPEUTIC AGENTS TO AN INTESTINAL WALL | VOKES, KATHLEEN PAIGE | 18d overdue |
| 18454947 | DRUG DELIVERY NEEDLE WITH ENHANCED PENETRATION CAPABILITY | GONZALEZ, LEI NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19105361 | AUTO-INFLATABLE PATCH ASSEMBLY FOR DELIVERY OF THERAPEUTIC AGENTS TO AN INTESTINAL WALL | VOKES, KATHLEEN PAIGE | 18d overdue |
| 17268507 | EXPANDABLE DRUG DELIVERY PILL | MARRISON, SAMUEL JOSEPH | 26d |
| 18454947 | DRUG DELIVERY NEEDLE WITH ENHANCED PENETRATION CAPABILITY | GONZALEZ, LEI NMN | — |
| Art Unit | Apps |
|---|---|
| 3783 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19105361 | AUTO-INFLATABLE PATCH ASSEMBLY FOR DELIVERY OF THERAPEUTIC AGENTS TO AN INTESTINAL WALL | VOKES, KATHLEEN PAIGE | 3783 | §103§112 | Final Rejection | 18d overdue | Pending | Feb 21, 2025 |
| 18454947 | DRUG DELIVERY NEEDLE WITH ENHANCED PENETRATION CAPABILITY | GONZALEZ, LEI NMN | 3783 | §102§103 | Final Rejection | — | Pending | Aug 24, 2023 |
| 17268507 | EXPANDABLE DRUG DELIVERY PILL | MARRISON, SAMUEL JOSEPH | 3783 | §103 | Non-Final OA | 26d | Pending | Feb 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial